Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun;58(6):2543-2557.
doi: 10.1007/s12035-020-02275-9. Epub 2021 Jan 19.

Motor Deficits Coupled to Cerebellar and Striatal Alterations in Ube3am-/p+ Mice Modelling Angelman Syndrome Are Attenuated by Adenosine A2A Receptor Blockade

Ana Moreira-de-Sá  1   2 , Francisco Q Gonçalves  1 , João P Lopes  1 , Henrique B Silva  1   2 , Ângelo R Tomé  1   3 , Rodrigo A Cunha  1   2 , Paula M Canas  4
Affiliations

Motor Deficits Coupled to Cerebellar and Striatal Alterations in Ube3am-/p+ Mice Modelling Angelman Syndrome Are Attenuated by Adenosine A2A Receptor Blockade

Ana Moreira-de-Sá et al. Mol Neurobiol. 2021 Jun.

Abstract

Angelman syndrome (AS) is a neurogenetic disorder involving ataxia and motor dysfunction, resulting from the absence of the maternally inherited functional Ube3a protein in neurons. Since adenosine A2A receptor (A2AR) blockade relieves synaptic and motor impairments in Parkinson's or Machado-Joseph's diseases, we now tested if A2AR blockade was also effective in attenuating motor deficits in an AS (Ube3am-/p+) mouse model and if this involved correction of synaptic alterations in striatum and cerebellum. Chronic administration of the A2AR antagonist SCH58261 (0.1 mg/kg/day, ip) promoted motor learning of AS mice in the accelerating-rotarod task and rescued the grip strength impairment of AS animals. These motor impairments were accompanied by synaptic alterations in cerebellum and striatum typified by upregulation of synaptophysin and vesicular GABA transporters (vGAT) in the cerebellum of AS mice along with a downregulation of vGAT, vesicular glutamate transporter 1 (vGLUT1) and the dopamine active transporter in AS striatum. Notably, A2AR blockade prevented the synaptic alterations found in AS mice cerebellum as well as the downregulation of striatal vGAT and vGLUT1. This provides the first indications that A2AR blockade may counteract the characteristic motor impairments and synaptic changes of AS, although more studies are needed to unravel the underlying mechanisms.

Keywords: Adenosine A2A receptor; Angelman syndrome; Cerebellum; Motor function; Striatum; Ube3a.

PubMed Disclaimer

References

    1. Mertz LG, Christensen R, Vogel I, Hertz JM, Nielsen KB, Gronskov K, Ostergaard JR (2013) Angelman syndrome in Denmark. birth incidence, genetic findings, and age at diagnosis. Am J Med Genet A 161A:2197–2203. https://doi.org/10.1002/ajmg.a.36058 - DOI - PubMed
    1. Buiting K, Williams C, Horsthemke B (2016) Angelman syndrome - insights into a rare neurogenetic disorder. Nat Rev Neurol 12:584–593. https://doi.org/10.1038/nrneurol.2016.133 - DOI - PubMed
    1. Kishino T, Lalande M, Wagstaff J (1997) Ube3a/E6-AP mutations cause Angelman syndrome. Nat Genet 15:70–73. https://doi.org/10.1038/ng0197-70 - DOI - PubMed
    1. Fang P, Lev-Lehman E, Tsai TF, Matsuura T, Benton CS, Sutcliffe JS, Christian SL, Kubota T et al (1999) The spectrum of mutations in Ube3a causing Angelman syndrome. Hum Mol Genet 8:129–135. https://doi.org/10.1093/hmg/8.1.129 - DOI - PubMed
    1. Yashiro K, Riday TT, Condon KH, Roberts AC, Bernardo DR, Prakash R, Weinberg RJ, Ehlers MD et al (2009) Ube3a is required for experience-dependent maturation of the neocortex. Nat Neurosci 12:777–783. https://doi.org/10.1038/nn.2327 - DOI - PubMed - PMC

MeSH terms

Substances

LinkOut - more resources